Alex B. Theventhiran

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/576fc3a0-1a58-11ed-b160-c3e1a0a4c1fe.jpg

First Name

Alex

Last Name

Theventhiran

NPI

1831403278

Faculty ID

14858

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

<p>Medical and surgical management of glaucoma, anterior segment surgery and complex cataracts.</p>

Research Focus

<p>Focus on optimization of diagnosis and treatment of glaucoma; analyzing and optimizing patient outcomes post surgery; analysis of post-operative treatment modalities; minimally invasive glaucoma surgery outcomes and analysis of post surgical findings/complication.</p>

Elsevier Profile

EMR ID

77650

Is Open Scheduling

Off

Jeffrey S. Schultz

https://assets.montefioreeinstein.org/profiles/images/physphoto/Schultz_Jeffrey_MD_420x504.jpg

First Name

Jeffrey

Last Name

Schultz

NPI

1417038845

Faculty ID

6010

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

<p>Medical, laser and surgical treatment of glaucoma.</p><p>Complex Cataract Surgery.</p>

Research Focus

<p>Use of &ldquo;Big Data&rdquo; and AI for Ophthalmology.</p><p>New Medical and Surgical Treatments for Glaucoma.</p><p>Effects of work flow changes on efficiency in ophthalmic practice.</p>

Elsevier Profile

EMR ID

3468

Biography

Dr. Schultz earned his medical degree at Mount Sinai School of Medicine and served as the Harold G Scheie fellow in glaucoma at the University of Pennsylvania. He is an associate examiner for the American Board of Ophthalmology and received an honorary award from the American Academy of Ophthalmology. He is presently Chairman of the Scientific Advisory Board of the Friends of the Congressional Glaucoma Caucus. He is currently investigating the effect of Flomax on the iris dilator muscle to help improve surgical outcomes in patients undergoing cataract surgery. In addition, he is involved in advancing the surgical uses for the Trabectome&reg;, a new surgical procedure for the treatment of glaucoma developed in part by a physician at Montefiore.

Is Open Scheduling

Off

Gene Kim

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/d8885df0-c947-11ed-8462-993dfb204153.jpg

First Name

Gene

Last Name

Kim

NPI

1033474820

Faculty ID

15473

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

<p>Medical and surgical management of glaucoma, including minimally invasive glaucoma surgery (MIGS),</p><p>Cataract surgery, including premium intraocular lenses.</p><p>Glaucoma laser procedures.</p>

Research Focus

<p>Safety and efficacy of minimally invasive glaucoma surgery (MIGS).</p><p>Post-operative outcomes after phacoemulsification cataract surgery.</p><p>Ocular coherence tomography (OCT) imaging in glaucoma management.</p>

Elsevier Profile

EMR ID

6047

Biography

<p>Gene Kim, MD, is an attending physician and Assistant Professor, Ophthalmology at Montefiore Einstein. A board-certified ophthalmologist with a clinical specialty in the treatment of glaucoma and cataracts, Dr. Kim&rsquo;s focus is on the medical and surgical management of glaucoma, including minimally invasive glaucoma surgery (MIGS), cataract surgery, including premium intraocular lenses, and glaucoma laser procedures</p><p>After receiving his Bachelor of Science in biology and psychology from Duke University in 2008, Dr. Kim attended University of Michigan Medical School, earning his Doctor of Medicine in 2012. His postdoctoral training began with a transitional year internship at Oakwood Hospital, followed by ophthalmology residency training at the Baylor College of Medicine Cullen Eye Institute from 2013 to 2016. He went on to complete a yearlong glaucoma fellowship at the Columbia University Edward S. Harkness Eye Institute in 2017.</p><p>Dr. Kim&rsquo;s research focuses on safety and efficacy of MIGS, post-operative outcomes after phacoemulsification cataract surgery and ocular coherence tomography (OCT) imaging in glaucoma management. He has shared his research through peer-reviewed journals, book chapters and regional and national presentations. He is also a reviewer for the <em>Journal of Glaucoma</em>.</p><p>Dr. Kim is a Diplomate of the American Board of Ophthalmology, and is a member of the American Glaucoma Society and the American Academy of Ophthalmology.</p>

Is Open Scheduling

Off

Roy S. Chuck

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/99124b00-b3a6-11ee-8ab8-012a307002d3.jpg

First Name

Roy

Last Name

Chuck

NPI

1447202338

Faculty ID

11721

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p class="bodycopy">Dr. Roy S. Chuck is an ophthalmologist, visual scientist and geneticist known for his stem cell and dry eye research, and work in corneal restoration. He chairs Einstein&rsquo;s department of ophthalmology and visual sciences, one of only a handful of Asian-Americans to hold such a post in the U.S.</p>
<p class="bodycopy">&nbsp;</p>
<p class="bodycopy">He also chairs the ophthalmology department at Montefiore Medical Center, overseeing tertiary care to adult and pediatric patients with diseases of the eye, with subspecialty expertise that includes neuro-ophthalmology, plastic surgery, and retina, cornea and glaucoma services. The department maintains a program of ongoing community outreach aimed at early detection and treatment of eye diseases.</p>
<p class="bodycopy">&nbsp;</p>
<p class="bodycopy">Dr. Chuck is a cornea specialist with expertise in laser techniques for refractive eye conditions. He has deep research experience and holds multiple patents. His two main areas of research are corneal stem cell surgery and dry eye, the most common global eye disease. Recently, Dr. Chuck's team developed a unique mouse model of dry eye that allows animal testing of therapies. The model employs the use of <em>botulinum</em> toxin, commonly known as "botox," to block neurotransmitters in the tear-producing lacrimal gland. The resulting dry eye closely mimics that found in humans.</p>
<p class="bodycopy">&nbsp;</p>
<p class="bodycopy">Dr. Chuck is a long-time stem cell investigator in connection with corneal transplantation and sight restoration. His work includes cutting-edge corneal stem cell surgery, which has a success rate of nearly 50-percent&mdash;one of the highest for stem cell surgery.&nbsp; The operation is performed if the stem cell pool on the eye is wiped out through injury or a genetic condition. Without these regenerating cells, eye injuries, however small, result in opaque scars that reduce or even eliminate vision. Corneal stem cell surgery requires removing the scar tissue and transplanting donated corneal stem cells onto the eye. If successful, the introduced stem cells heal the wound and vision is restored.</p>
<p class="bodycopy">&nbsp;</p>
<p class="bodycopy">At Einstein, Dr. Chuck is developing research centers focusing on ophthalmologic disorders including cataracts, ocular surface disease/dry eye, glaucoma, macular degeneration, and eye conditions associated with diabetes.</p>

Research Areas

Specialties

Expert Tags

Areas of Expertise

Expert Summary

<div>Dr. Chuck is a prominent stem cell and dry eye researcher. He is a cornea specialist with expertise in the field of laser techniques, including LASIK surgery, corneal replacement, stem cell surgery, and refractive eye problems.&nbsp;</div>
<div><br />A basic scientist as well as a clinical researcher, Dr. Chuck has helped develop a unique model of dry eye using Botox that allows for testing of preclinical therapies. He has served as principal investigator on five FDA studies of vision correction and written more than 175 peer-reviewed papers and more than 100 book chapters and abstracts. Dr. Chuck has been featured several times on ABC News and ABC&rsquo;s &ldquo;Good Morning America&rdquo; on various eye diseases and conditions. He serves on the editorial boards of several publications, including the <em>Journal of Refractive Surgery</em> and <em>Lasers in Surgery and Medicine</em>.&nbsp;</div>

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Refractive surgery and corneal disorders including dry eye

Research Focus

Corneal reconstruction and stem cell surgery, dry eye, refractive surgery

Elsevier Profile

EMR ID

5233

Biography

<p>Roy S. Chuck, MD, PhD, is Chairman and Professor, Ophthalmology &amp; Visual Sciences at Montefiore Einstein. Dr. Chuck&rsquo;s clinical focus is in cornea and external diseases as well as refractive surgery.</p><p>After earning his Bachelor of Science in engineering at University of California, Berkeley, in 1986, Dr. Chuck attended Columbia University, earning his Doctor of Medicine and Doctor of Philosophy in 1993. He started his postdoctoral training at St. Mary&rsquo;s Health Center, completing a yearlong internship in internal medicine in 1994. From then until 1998, he pursued a residency in ophthalmology at Washington University and Barnes Hospital, acting as chief resident in his final year. In 1999, he completed a yearlong fellowship in cornea and refractive surgery at Doheny Eye Institute, University of Southern California.</p><p>Dr. Chuck&rsquo;s research has been published in numerous peer-reviewed journals as well as shared through many abstracts, book chapters and podium and poster presentations. He has been an editor and served on the editorial boards of many publications including the <em>Lasers in Surgery and Medicine, Journal of Refractive Surgery, Current Opinion in Ophthalmology and BMC Ophthalmology</em>. He currently serves as the Editor-in-Chief of the major journal <em>ARVO Translational Vision Science and Technology</em> and is a member of the NIH National Eye Institute Council of Editors.</p><p>Dr. Chuck is board certified and is a member of many local, national and international professional societies including the International Society for Refractive Surgery, the American Society for Laser Medicine and Surgery, and the Manhattan Ophthalmological Society. He currently serves as Secretary for Quality of Care for the American Academy of Ophthalmology.</p>

Is Open Scheduling

Off